ACADIA Pharmaceuticals Inc.

Advancing treatment in neurological disorders and rare diseases. Its commercial portfolio includes FDA-approved treatments for Parkinson's disease psychosis and Rett syndrome; its pipeline includes programs in Alzheimer's disease psychosis and Lewy body dementia psychosis. Source

Keywords: neurological disorders rare disease Parkinson's disease psychosis Rett syndrome Alzheimer's disease psychosis Lewy body dementia psychosis Show all 6 keywords